full
border
#666666
http://www.arboretumvc.com/wp/wp-content/themes/zap-installable/
https://www.arboretumvc.com/wp/
#ffffff
style1

Strata Oncology News

02
Jan

Three years after stepping down from the top job at Entergy Corp., New Orleans’ lone Fortune 500 firm, Wayne Leonard’s retirement took a bad turn. After being diagnosed with stage 4 lung cancer,Leonard was referring to Ochsner Medical Center on Jefferson Highway, where he is involved in a new initiative designed to tailor a cancer patient’s treatment to information found within their tumor’s genetic profile. That information can be used to match patients with early-phase clinical trials and enable them to participate in innovative therapies still under development.

Link

13
Dec

Strata Oncology, a precision oncology company, today announced five leading healthcare systems have joined the Strata Precision Oncology Network™ (Network). Launched in February of 2017, and led by Strata Oncology, the Network is advancing precision oncology by providing advanced cancer patients routine tumor profiling and matching to a portfolio of biomarker-matched pharma-sponsored clinical trials.
Link

04
Oct

Strata Oncology, Inc. (Strata), a precision oncology company, announced a collaboration with the University of California San Francisco (UCSF) to launch Stratify Prostate™ a unique initiative focused on expanding access to tumor sequencing nationwide for men with advanced prostate cancer and to dramatically accelerate enrollment into relevant targeted therapy trials.

Link

22
May

The University of Alabama at Birmingham Comprehensive Cancer Center announces its partnership with Strata Oncology to provide patients with advanced or rare cancers with tumor profiling or sequencing at no cost. This will include primarily those with metastatic disease or whose tumors cannot be removed surgically, and will also be available to all glioblastoma and pancreatic cancer patients.
Link

02
Feb

Clovis Oncology, Inc. (NASDAQ: CLVS) and Strata Oncology, Inc. today announced an agreement to accelerate patient identification and enrollment for Clovis’ ongoing TRITON (Trial of Rucaparib in Prostate Indications) clinical trial program, which includes Phase 2 and Phase 3 clinical trials of rucaparib in metastatic castration-resistant prostate cancer, both of which are open for enrollment.

Link

01
Jun

Strata Oncology, a precision medicine company, today announced the completion of a Series A financing of $12M. The financing will fuel Strata’s state-of-the-art tumor sequencing operation and implementation of the Strata Trial, a nation-wide effort aimed at substantially increasing the number of enrollments in precision medicine clinical trials. Arboretum Ventures and Baird Capital co-led the financing, with additional funding provided by Strata’s existing investor, Michigan eLab.

Link

1
1
scrollauto
Loading posts...
link_magnifier
#ffffff
on
loading
off